Vireo Growth (VREOF) Operating Income (2020 - 2026)
Vireo Growth's (VREOF) quarterly Operating Income came in at $9.0 million in Q1 2026, up 350.0% year-on-year from $2.0 million in Q1 2025, and up 596.02% quarter-over-quarter from -$1.8 million in Q4 2025.
Vireo Growth (VREOF) Operating Income (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Operating Income across 7 years of filings, most recently posting $9.0 million for Q1 2026.
- Operating Income for Q1 2026 came in at $9.0 million, up 350.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 44.69% YoY), and the FY2025 annual result was -$1.0 million, down 107.73% from the prior year.
- Operating Income came in at $9.0 million for Q1 2026 at Vireo Growth, up from -$1.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $9.0 million in Q1 2026 to a low of -$7.8 million in Q1 2022.
- The 5-year median for Operating Income is $701765.0 (2022), against an average of $1.5 million.
- Peak annual rise in Operating Income reached 3204.05% in 2023, while the deepest fall reached 438.12% in 2023.
- Vireo Growth's Operating Income stood at $701765.0 in 2022, then soared by 666.9% to $5.4 million in 2023, then slumped by 115.64% to -$841550.0 in 2024, then plunged by 115.61% to -$1.8 million in 2025, then jumped by 596.02% to $9.0 million in 2026.
- The last three Operating Income figures came in at $9.0 million (Q1 2026), -$1.8 million (Q4 2025), and $808956.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -1.81 Mn |
| Sep 30, 2025 | 808,956.00 |
| Jun 30, 2025 | -2.02 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | -841,550.00 |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | -1.04 Mn |
| Mar 31, 2023 | 368,506.00 |
| Dec 31, 2022 | 701,765.00 |
| Sep 30, 2022 | -189,156.00 |
| Jun 30, 2022 | 308,185.00 |
| Mar 31, 2022 | -7.76 Mn |
| Dec 31, 2021 | -8.26 Mn |
| Sep 30, 2021 | -4.13 Mn |
| Jun 30, 2021 | -3.25 Mn |